It is intended to provide medicines having a higher ocular tension-lowering effect on ocular hypertension and glaucoma. Because of showing an excellent effect of lowering ocular tension, medicines comprising a combination of a prostaglandin compound with an NO-donating compound are useful in treating ocular hypertension and glaucoma.
申请公布号
WO02085372(A1)
申请公布日期
2002.10.31
申请号
WO2002JP03292
申请日期
2002.04.02
申请人
TEIKA PHARMACEUTICAL CO., LTD.;KOWA COMPANY LTD.;ORIHASHI, MASAHIRO;KOIKE, JUNPEI;MASUDA, KANAKO
